We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+14.14%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$3.86B
AUM Growth
+$129M
Cap. Flow
-$222M
Cap. Flow %
-5.74%
Top 10 Hldgs %
5.3%
Holding
1,514
New
109
Increased
323
Reduced
286
Closed
149

Top Buys

Rank Stock Value
1
EBAY icon
eBay
EBAY
+$10.9M
2
SASR
Sandy Spring Bancorp Inc
SASR
+$8.99M
3
T icon
AT&T
T
+$8.64M
4
RRR icon
Red Rock Resorts
RRR
+$8.46M
5
MCY icon
Mercury Insurance
MCY
+$8.11M

Top Sells

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$19.9M
2
CRK icon
Comstock Resources
CRK
+$15.5M
3
SM icon
SM Energy
SM
+$14.3M
4
AR icon
Antero Resources
AR
+$14.2M
5
MCK icon
McKesson
MCK
+$12.9M

Sector Composition

Rank Sector Weight
1 Financials 28.28%
2 Consumer Discretionary 11.1%
3 Industrials 10.71%
4 Energy 9.76%
5 Technology 9.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ONCR
1351
DELISTED
Oncorus, Inc.
ONCR
$17K ﹤0.01%
67,300
OGEN icon
1352
Oragenics
OGEN
$2.48M
$14.7K ﹤0.01%
78
NSPR icon
1353
InspireMD
NSPR
$34.7M
$14.3K ﹤0.01%
16,667
CPHI icon
1354
China Pharma Holdings
CPHI
$45.8M
$13.9K ﹤0.01%
290
TOVX icon
1355
Theriva Biologics
TOVX
$10.1M
$13K ﹤0.01%
1,141
LHDX
1356
DELISTED
Lucira Health, Inc. Common Stock
LHDX
$12.3K ﹤0.01%
110,500
-14,200
-11% -$9.06K
NEXI
1357
DELISTED
NexImmune, Inc. Common Stock
NEXI
$12.2K ﹤0.01%
2,000
IBIO icon
1358
iBio
IBIO
$70M
$11.1K ﹤0.01%
+1,250
New +$42.3K
PHGE icon
1359
BiomX
PHGE
$1.85M
$9.24K ﹤0.01%
261
-48
-16% -$2.65K
SIOX
1360
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$6.79K ﹤0.01%
15,600
-89,800
-85% -$29.1K
XWEL icon
1361
XWELL
XWEL
$8.61M
$6.06K ﹤0.01%
835
ALLR
1362
Allarity Therapeutics
ALLR
$22.1M
0
LGL.WS
1363
DELISTED
LGL Group Inc Warrants
LGL.WS
$5.84K ﹤0.01%
29,200
RUBY
1364
DELISTED
Rubius Therapeutics, Inc
RUBY
$4.34K ﹤0.01%
25,200
GNLN icon
1365
Greenlane Holdings
GNLN
$1.23M
0
ABG icon
1366
Asbury Automotive
ABG
$3.85B
-21,600
Closed -$3.26M
ADVM
1367
DELISTED
Adverum Biotechnologies
ADVM
-29,900
Closed -$284K
AIRI icon
1368
Air Industries Group
AIRI
$12.8M
-9,000
Closed -$59K
AMAT icon
1369
Applied Materials
AMAT
$428B
-18,500
Closed -$1.52M
AMR icon
1370
Alpha Metallurgical Resources
AMR
$1.93B
-62,200
Closed -$8.51M
ANDE icon
1371
Andersons Inc
ANDE
$2.22B
-104,516
Closed -$3.24M
APRE icon
1372
Aprea Therapeutics
APRE
$8.05M
-1,000
Closed -$13K
AR icon
1373
Antero Resources
AR
$10.7B
-466,600
Closed -$14.2M
ATKR icon
1374
Atkore
ATKR
$3.16B
-5,400
Closed -$420K
BF.B icon
1375
Brown-Forman Class B
BF.B
$13.1B
-63,800
Closed -$4.25M

Similar funds

Bridgeway Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Bridgeway Capital Management held 1,514 positions worth $3.86B, up 3.4% from $3.73B the previous quarter. Its ten largest holdings account for 5.3% of the portfolio.

Bridgeway Capital Management withdrew a net $222M in Q4 2022, closing 149 positions and reducing 286 holdings. Its most notable exit was Comstock Resources, an estimated $15.5M position sold in full.

By sector, the portfolio is most concentrated in Financials at 28% of assets, up from 27% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Bridgeway Capital Management opened a new position in eBay worth $10.9M.

  • Bridgeway Capital Management's largest Q4 2022 buy was eBay: 263,700 shares worth $10.9M.
  • Bridgeway Capital Management added most to AT&T in Q4 2022, an estimated $8.64M increase.
  • Bridgeway Capital Management's biggest Q4 2022 reduction was ExxonMobil, cutting an estimated $19.9M.
  • Bridgeway Capital Management fully exited Comstock Resources in Q4 2022, selling an estimated $15.5M.
  • Bridgeway Capital Management's ten largest holdings make up 5.3% of its $3.86B portfolio in Q4 2022.
  • Bridgeway Capital Management opened 109 new positions and closed 149 in Q4 2022.
  • Bridgeway Capital Management's portfolio value rose 3.4% quarter-over-quarter to $3.86B.

Based on Bridgeway Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.